SCHEMBL6539670

SCHEMBL6539670

COc1ccc(C(=O)C(NC(=O)C(=O)O)c2ccc(OC)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.49
CYP1A2 P05177 1/20 0.49
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CYP3A4 P08684 1/20 0.47
GAA P10253 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 1/20 0.46
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
CES2 O00748 2/20 0.44
CES1 P23141 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
PLK1 P53350 1/20 0.44
CNR2 P34972 1/20 0.43
CYP19A1 P11511 1/20 0.43
ANPEP P15144 1/20 0.43
SLC2A1 P11166 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6540335 0.87 RAB9A (0.52) ALDH1A1POLBMAPTNPC1RAB9A
SCHEMBL6258849 0.87 RAB9A (0.52) ALDH1A1POLBMAPTNPC1RAB9A
SCHEMBL9147656 0.81 HPGD (0.54) ALDH1A1GAAMAPTMEN1NPC1
SCHEMBL22215186 0.78 MDM2 (0.55) ALDH1A1CYP1A2CA1CA2GAA
SCHEMBL22215196 0.78 ALDH1A1 (0.57) ALDH1A1CYP1A2CYP3A4GAAPOLB
SCHEMBL17193732 0.78 ACACB (0.59) ALDH1A1CA1CA2GAAMEN1
SCHEMBL17193733 0.78 ACACB (0.59) ALDH1A1CA1CA2GAAMEN1
SCHEMBL6222701 0.77 CA1 (0.47) ALDH1A1CYP1A2CA1CA2CYP3A4
SCHEMBL11697241 0.74 ATM (0.56) ALDH1A1CYP1A2CA1CA2CYP3A4
SCHEMBL9151342 0.74 HDAC8 (0.50) ALDH1A1CYP1A2GAAMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040157891-A1 Inhibitor of cox FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157891-A1 Inhibitor of cox PTGS1, PTGS2, PTGES2 ALDH1A1 163/4885CYP1A2 33/4885CA1 1632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.